Season 25 Episode 19
Dr Rinath M Jeselsohn from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses recent developments with oral SERDs in the management of ER-positive metastatic breast cancer.
CME information and select publications here.
Published on 3 months, 1 week ago
If you like Podbriefly.com, please consider donating to support the ongoing development.
Donate